Alport syndrome: Expanding diagnosis and treatment
Alport syndrome (AS) is the second common monogenic cause of end-stage kidney disease (ESKD) worldwide and is caused by defective type 4 collagen due to pathogenic variants of COL4A3, COL4A4, or COL4A5. Type 4 collagen also exists in the eyes and ears, and thus ocular defects and hearing loss occur...
Saved in:
| Main Authors: | Hou-Xuan Huang, I-Jung Tsai, Larry A. Greenbaum |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Pediatrics and Neonatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957224001918 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alport syndrome
by: Karen Angela L. Tiuseco, MD, et al.
Published: (2011-12-01) -
Alport's Syndrome in Pregnancy
by: Suchita Mehta, et al.
Published: (2013-01-01) -
Analysis of the Treatment Efficacy in Late Diagnosis of Alport Syndrome in a Child: Clinical Case
by: Svetlana Ya. Volgina, et al.
Published: (2023-12-01) -
Biomarkers for the early diagnosis of Alport syndrome and associated kidney damage
by: Hong Duc Thi Nguyen, et al.
Published: (2025-02-01) -
Alport syndrome with urethral leiomyoma: A case report
by: LiQin Gu, et al.
Published: (2025-05-01)